Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoviPrep: FTC/TAF for COVID-19 PrEP in Healthcare Workers
NCT04405271Phase 3Terminated
- Sponsor
- Hospital Italiano de Buenos Aires
- Start
- Jul 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of emtricitabine + tenofovir alafenamide in coronavirus disease 2019 (COVID-19), sponsored by Hospital Italiano de Buenos Aires. Started Jul 2020; status: terminated.
02
Drugs
emtricitabine + tenofovir alafenamide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04405271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04405271.